The ban, in other words, was never proof that BPC-157 works
It is being developed primarily as a treatment for obesity and type 2 diabetes, but its potential applications extend to several weight-related conditions including non-alcoholic fatty liver disease (NAFLD), knee osteoarthritis, and obstructive sleep apnoea
The intraoral lesions usually occur in patients older than 40
International Journal of Molecular Sciences, 24(8), 4567-4582.
It's a foundational scientific procedure that dictates the stability, efficacy, and ultimately, the validity of your research outcomes
So, whats actually happening here